Evaluation of the efficacy and tolerability of a new intermittent treatment regimen with cyclosporin A in severe psoriasis;Valutazione dell'efficacia e della tollerabilità di un nuovo schema di terapia intermittente con ciclosporina A nella psoriasi severa

Giornale Italiano di Dermatologia e Venereologia

Volumn 140, Issue 5, 2005, Pages 575-582

  Vena, G A ^a   Cassano, N ^a   Galluccio, A ^b   Loconsole, F ^a   Coviello, C ^a   Fai, D ^c   Dattola, S ^d   Ferrari, A ^d   Ligori, P ^c   Lopreiato, R ^d   Pelle, S ^c   Postorino, M F ^d   Ricciuti, F ^e   Valenti, G ^f   Malvindi, C ^c   Lui, P ^g  

^a UNIVERSITY OF BARI   (Italy)

^b Unit of Dermatology   (Italy)

^c Collegio Salentino di Dermatologia CSD ^*  (Italy)

^d ADMG   (Italy)

^e SAN CARLO HOSPITAL   (Italy)

^f Ospedale di Catanzaro   (Italy)

^g ASL Provincia di Mantova   (Italy)

Author keywords

Cyclosporin A; Psoriasis, diagnosis; Psoriasis, therapy

Indexed keywords

CYCLOSPORIN A;

ABDOMINAL PAIN; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BRONCHITIS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG TOLERABILITY; DYSPEPSIA; EVALUATION; FEMALE; FREQUENCY ANALYSIS; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; OUTCOME ASSESSMENT; PRURITUS; PSORIASIS; RASH; TREATMENT WITHDRAWAL; VOMITING;

EID: 33745360229     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Griffiths CE, Clark CM, Chalmers RJ, Li Wan Po A, Williams HC. A systematic review of treatments for severe psoriasis. Health Technol Assess 2000;4:1-125.
2. Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K et al. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol 1998;39:464-75.
3. Berth-Jones J. Current management of psoriasis. Cyclosporin. J Derm Treat 1997;8:46-9.
4. Koo J. Neoral in psoriasis therapy: toward a new perspective. Int J Dermatol 1997;36Suppl 1:25-9.
5. Ho VC. The use of ciclosporin in psoriasis: a clinical review. Br J Dermatol 2004:150 Suppl 67:1-10.
6. Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AW. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001;144:967-72.
7. Salek MS, Finlay AY, Lewis JJ, Sumner MI. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral). Qual Life Res 2004;13:91-5.
8. Griffiths CEM, Dubertret L, Ellis CN, Finlay AY, Finzi AF, Ho VC et al. Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol 2004;150 Suppl. 67:11-63.
9. Finzi AF. Individualized short-course cyclosporin therapy in psoriasis. Br J Dermatol 1996;135 Suppl 48:31-4.
10. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a newretinoid. Dermatologica 1978;157:238-44.
11. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
12. Vena GA, Cassano N. Terapia sistemica nella psoriasi. In: Lotti MT, editor. La psoriasi. Verso il terzo millennio: generalità e nuove acquisizioni. Milano: Utet Periodici Scientifici; 1999.p.168-76.
13. Zachariae H, Kragballe K, Hansen HE, Marcussen N, Olsen S. Renal biopsy findings in long-term cyclosporin treatment of psoriasis. Br J Dermatol 1997;136:531-5.
14. Powles AV, Hardman CM, Porter WM, Cook T, Hulme B, Fry L. Renal function after 10 years' treatment with cyclosporin for psoriasis. Br J Dermatol 1998;138:443-9.
15. Berth-Jones J, Henderson CA, Munro CS, Rogers S, Chalmers RJ, Boffa MJ et al. Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study. Br J Dermatol 1997;136:527-30.
16. Ozawa A, Sugai J, Ohkido M, Ohtsuki M, Nakagawa H, Kitahara H et al. Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy. Eur J Dermatol 1999;9:218-23.
17. Ho VC, Griffiths CE, Albrecht G, Vanaclocha F, Leon-Dorantes G, Atakan N et al. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. Br J Dermatol 1999;141:283-91.
18. Ho VC, Griffiths CE, Berth-Jones J, Papp KA, Vanaclocha F, Dauden E et al. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study. J Am Acad Dermatol 2001;44:643-51.
19. Brown AL, Wilkinson R, Thomas TH, Levell N, Munro C, Marks J et al. The effect of short-term low-dose cyclosporin on renal function and blood pressure in patients with psoriasis. Br J Dermatol 1993;128:550-5.
20. Vena GA, Coviello C, Foti C, Curatoli G, Mastrolonardo M. Ciclosporina A nella psoriasi: mantenimento dell'efficacia clinica con somministrazione intervallata. Chron Derm 1994;4:639-45.
21. Thaci D, Brautigam M, Kaufmann R, Weidinger G, Paul C, Christophers E. Body-weight-independent dosing of cyclosporine microemulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study. Dermatology 2002;205:383-8.
22. Goodman MM, White GM, McCormick A, McCullough J, Weinstein G. Cyclosporine therapy for psoriasis: a cell cycle-derived dosing schedule. J Am Acad Dermatol 1992;27:594-8.